Cel-Sci ( Cel-Sci )

Cel-Sci

Cel-Sci's picture

About Cel-Sci

Cel-Sci Press Release and News

Cel-Sci press release, blog etc

09/14/2018 - 04:39 CEL-SCI RECEIVES $5.4 MILLION FROM WARRANT EXERCISES
09/05/2018 - 19:21 NIH SELECTS CEL-SCI's LEAPS RHEUMATOID ARTHRITIS VACCINE FOR COMMERCIALIZATION ACCELERATOR PROGRAM
07/12/2018 - 23:40 CEL-SCI REPORTS ON NYSE AMERICAN NONCOMPLIANCE NOTICE AND COMPLIANCE PLAN
06/27/2018 - 15:10 CEL-SCI WINS BREACH OF CONTRACT RULING AGAINST CLINICAL RESEARCH ORGANIZATION INVENTIV, NOW KNOWN AS SYNEOS HEALTH
06/08/2018 - 06:14 U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENTS FOR LEAPS VACCINE PLATFORM TECHNOLOGY
05/22/2018 - 05:13 CEL-SCI CORPORATION TO PRESENT AT THE 8TH ANNUAL LD MICRO INVITATIONAL
05/02/2018 - 08:34 CEL-SCI CORPORATION ANNOUNCES UPCOMING INVESTOR CONFERENCE PRESENTATIONS
04/09/2018 - 05:34 CEL-SCI CORPORATION TO PRESENT AT THE MICROCAP CONFERENCE
02/05/2018 - 15:21 CEL-SCI TO PRESENT AT 2018 BIO CEO & INVESTOR CONFERENCE
01/30/2018 - 16:54 U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENT FOR LEAPS VACCINE PLATFORM TECHNOLOGY
01/16/2018 - 12:34 CEL-SCI ANNOUNCES ADJUSTMENT TO WARRANT EXERCISE PRICE
01/08/2018 - 12:06 CEL-SCI AWARDED PATENT FOR LEAPS VACCINE IN TREATMENT OF RHEUMATOID ARTHRITIS
12/29/2017 - 15:05 CEL-SCI REPORTS FISCAL 2017 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
12/18/2017 - 16:18 CEL-SCI ANNOUNCES ROBERT WATSON JOINS ITS BOARD OF DIRECTORS
12/11/2017 - 12:48 CEL-SCI REACHES FULL ENROLLMENT IN PIVOTAL PHASE 3 HEAD AND NECK CANCER STUDY
11/13/2017 - 12:13 CEL-SCI ANNOUNCES UPDATE ON ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
10/10/2017 - 05:54 CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE'S MECHANISM OF ACTION IN MAKING TUMORS 'VISIBLE' TO THE IMMUNE SYSTEM
10/05/2017 - 09:17 CEL-SCI ANNOUNCES UPDATE ON ONGOING ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION